150 related articles for article (PubMed ID: 19585173)
1. Complete response of an initially non-surgical adenocarcinoma of the duodenum to chemotherapy with the FOLFOX 4 regimen.
Manfredi S; Thiebot T; Henno S; Falize L; Bretagne JF; Meunier B
J Gastrointest Surg; 2009 Dec; 13(12):2309-13. PubMed ID: 19585173
[TBL] [Abstract][Full Text] [Related]
2. [Surgical Resection and Adjuvant Chemotherapy with FOLFOX6 for Primary Duodenal Adenocarcinoma and Nodal Metastasis Resulted in Complete Remission].
Imamura Y; Sasaki M; Kouyama M; Tazaki T; Sugiyama Y; Nakamura H; Kuroo Y; Nakamitsu A; Daimaru Y; Yabuta Y; Shirai A; Uzuhashi K
Gan To Kagaku Ryoho; 2016 May; 43(5):629-31. PubMed ID: 27210097
[TBL] [Abstract][Full Text] [Related]
3. A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.
Catania C; Pelosi G; Fazio N; Biffi R; Spitaleri G; Noberasco C; Zampino MG; Maggioni A; Trifirò G; Toffalorio F; Vigna PD; De Braud F; De Pas T
Acta Oncol; 2010; 49(1):120-1. PubMed ID: 20100147
[No Abstract] [Full Text] [Related]
4. [mFOLFOX6 chemotherapy enabling curative resection in a patient with locally advanced duodenal adenocarcinoma and lymph node metastases].
Sasaki H; Kaneto H; Iida T; Naganawa Y; Satoh S; Shimizu H; Sasaki K; Konishi Y; Kon S
Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2135-43. PubMed ID: 26638785
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma.
Xiang XJ; Liu YW; Zhang L; Qiu F; Yu F; Zhan ZY; Feng M; Yan J; Zhao JG; Xiong JP
Anticancer Drugs; 2012 Jun; 23(5):561-6. PubMed ID: 22481063
[TBL] [Abstract][Full Text] [Related]
6. [A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases].
Fujiwara Y; Naomoto Y; Tanabe S; Sakurama K; Noma K; Nishikawa T; Motoki T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Tanaka N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):655-7. PubMed ID: 19381042
[TBL] [Abstract][Full Text] [Related]
7. Multiorgan failure in a patient treated with the 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan regimen.
Schwartzman AD; Sethi R; Smith R
Clin Colorectal Cancer; 2013 Jun; 12(2):136-9. PubMed ID: 23098664
[No Abstract] [Full Text] [Related]
8. Neoadjuvant Treatment With Trastuzumab and FOLFOX Induces a Complete Pathologic Response in a Metastatic
Hamad A; Singhi AD; Bahary N; McGrath K; Amarin R; Zeh HJ; Zureikat AH
J Natl Compr Canc Netw; 2017 Aug; 15(8):983-988. PubMed ID: 28784859
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
Guo XC; Mao ZY; Su D; Wang LJ; Zhang TT; Bai L
Cancer Invest; 2014 Jun; 32(5):178-83. PubMed ID: 24654694
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China.
Zhang L; Wang LY; Deng YM; Wang FH; Feng F; Chen YC; An X; Chen C; Xu RH; Li YH
J BUON; 2011; 16(4):689-96. PubMed ID: 22331723
[TBL] [Abstract][Full Text] [Related]
11. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
[TBL] [Abstract][Full Text] [Related]
12. [FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].
Yan D; Dai H
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):217-9. PubMed ID: 19615264
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin/5-fluorouracil/leucovorin (FOLFOX4) regimen as an adjuvant chemotherapy in the treatment of advanced jejunal adenocarcinoma: a report of 2 cases.
Chen CW; Wang WM; Su YC; Wu JY; Hsieh JS; Wang JY
Med Princ Pract; 2008; 17(6):496-9. PubMed ID: 18836281
[TBL] [Abstract][Full Text] [Related]
14. Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study.
Mary F; Zaanan A; Boige V; Artru P; Samalin E; Coriat R; Bachet JB; Boubaya M; Benallaoua M; Tougeron D; Afchain P; Locher C; Baumgaertner I; Lecaille C; des Guetz G; Aparicio T;
Dig Liver Dis; 2016 Dec; 48(12):1498-1502. PubMed ID: 27623185
[TBL] [Abstract][Full Text] [Related]
15. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
Amini A; Sanati H
Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
17. Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: report of a case.
Park JM; Chi KC
World J Surg Oncol; 2010 Dec; 8():109. PubMed ID: 21167074
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma.
Velut G; Mary F; Wind P; Aparicio T
Dig Liver Dis; 2014 Dec; 46(12):1135-6. PubMed ID: 25179158
[No Abstract] [Full Text] [Related]
19. Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab.
Mochizuki S; Yoshino T; Kojima T; Fuse N; Ikematsu H; Minashi K; Yano T; Tahara M; Kaneko K; Doi T; Koike K; Ohtsu A
Jpn J Clin Oncol; 2010 Oct; 40(10):933-7. PubMed ID: 20494948
[TBL] [Abstract][Full Text] [Related]
20. Complete response of primary bladder adenocarcinoma with the FOLFOX4 regimen.
Tatli AM; Uysal M; Goksu SS; Gunduz S; Arslan D; Ozdogan M
Urol Int; 2015; 94(3):363-5. PubMed ID: 24281125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
